Companies: 10,795·Total market cap: $144.5T
Ono Pharmaceutical Co., Ltd.

Ono Pharmaceutical Co., Ltd.

OPHLYOTCHealthcare● Active
$4.63
+$0.08(+1.76%)
Market Cap$6.5B
P/E Ratio
52W High$5.75
52W Low$3.35
Overview

Ono Pharmaceutical Co., Ltd. (OPHLY) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · OPHLY · as of Jun 9, 2026

Key Statistics

EPS (TTM)$49.98ophly eps ttm · ophly earnings per shareEarnings history
PE Ratio (TTM)0.1×ophly pe ratio ttm · ophly price to earningsPE Ratio deep dive
Revenue (TTM)$522.8Bophly revenue ttm · ophly annual revenueFull revenue history
Dividend Yield6.45%does ophly pay dividends · ophly dividend yieldDividend history
Shares Outstanding1.41Bophly shares outstanding · ophly floatShares outstanding history
Next EarningsAug 3, 2026Est.ophly earnings date · ophly next earningsEarnings history

Financial Snapshot

Full Financials
FY 2026Revenue$546.89B▲ +12.33% YoY
202420252026
ono pharmaceutical co., ltd. revenue · ophly revenue 2026
FY 2026Net Income$73.97B▲ +47.81% YoY
202420252026
ono pharmaceutical co., ltd. net income · ophly profit 2026
FY 2026EPS$52.73▲ +48.45% YoY
202420252026
ophly eps · ono pharmaceutical co., ltd. earnings per share 2026
TTM:Revenue: $522.75BNet Income: $70.78BEPS: $49.98View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Sell2 analystsis ophly a buy · ophly analyst rating
Strong Buy
0
Buy
0
Hold
0
Sell
2
Strong Sell
0
12-Month Price Target
$Low
$4.63Current
$Avg Target
$High
ophly price target · ophly 12 month forecast

Total: 2 · Buy rate: 0.0%

Stock Performance

Full History
1D+1.76%
1W+3.58%
1M-11.47%
3M-11.81%
YTD+1.76%
1Y+33.05%
5Y-36.92%

About Ono Pharmaceutical Co., Ltd.

CEOGyo Sagara
IPO DateOct 2, 2012
Employees3,853
CountryJP

Ono Pharmaceutical Co., Ltd. along with its subsidiaries, operates globally, engaging in the research, development, procurement, and commercialization of pharmaceutical products and diagnostic reagen…

what is ono pharmaceutical co., ltd. · ophly stock overview · ono pharmaceutical co., ltd. company profile · who is ono pharmaceutical co., ltd. ceo · ophly OTC · ono pharmaceutical co., ltd. headquarters · ono pharmaceutical co., ltd. business segments

About Stock Overview & Key Data

Ono Pharmaceutical Co., Ltd. (OPHLY) is a Healthcare company in the Drug Manufacturers - General industry, listed on OTC since Oct 2, 2012. As of the latest trading session, OPHLY stock price is $4.63, with a market capitalization of $6.5B. The stock has returned +33.05% over the past 12 months and +1.76% year-to-date.

According to 2 Wall Street analysts, the consensus rating for Ono Pharmaceutical Co., Ltd. stock is Sell, with an average 12-month price target of $—. In fiscal year 2026, Ono Pharmaceutical Co., Ltd. reported revenue of $546.9B and net income of $74.0B. For detailed data — including Ono Pharmaceutical Co., Ltd. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Ono Pharmaceutical Co., Ltd. (OPHLY) stock price is $4.63. The stock is traded on OTC under the ticker symbol OPHLY. The 52-week range is $3.35 – $5.75.

OPHLY stock priceOPHLY quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice